Autocrine	0	9	O
angiogenic	10	20	O
vascular	21	29	O
prosthesis	30	40	O
with	41	45	O
bone	46	50	B-Multi-tissue_structure
marrow	51	57	I-Multi-tissue_structure
transplantation	58	73	O
.	73	74	O

Synthetic	76	85	O
vascular	86	94	O
prostheses	95	105	O
are	106	109	O
foreign	110	117	O
bodies	118	124	O
,	124	125	O
so	126	128	O
that	129	133	O
blood	134	139	B-Organism_substance
coagulation	140	151	O
can	152	155	O
occur	156	161	O
on	162	164	O
their	165	170	O
luminal	171	178	O
surfaces	179	187	O
,	187	188	O
causing	189	196	O
graft	197	202	O
occlusion	203	212	O
very	213	217	O
frequently	218	228	O
in	229	231	O
prostheses	232	242	O
of	243	245	O
small	246	251	O
diameter	252	260	O
.	260	261	O

A	262	263	O
vascular	264	272	O
prosthesis	273	283	O
needs	284	289	O
angiogenesis	290	302	O
for	303	306	O
endothelialization	307	325	O
of	326	328	O
the	329	332	O
luminal	333	340	O
surface	341	348	O
,	348	349	O
as	350	352	O
endothelial	353	364	B-Cell
cells	365	370	I-Cell
have	371	375	O
natural	376	383	O
and	384	387	O
permanent	388	397	O
antithrombogenic	398	414	O
properties	415	425	O
.	425	426	O

To	427	429	O
induce	430	436	O
capillary	437	446	B-Tissue
growth	447	453	O
into	454	458	O
the	459	462	O
graft	463	468	O
,	468	469	O
we	470	472	O
developed	473	482	O
a	483	484	O
method	485	491	O
of	492	494	O
transplanting	495	508	O
bone	509	513	B-Cell
marrow	514	520	I-Cell
cells	521	526	I-Cell
,	526	527	O
which	528	533	O
are	534	537	O
primitive	538	547	O
,	547	548	O
strong	549	555	O
enough	556	562	O
to	563	565	O
survive	566	573	O
,	573	574	O
and	575	578	O
create	579	585	O
blood	586	591	B-Cell
cells	592	597	I-Cell
,	597	598	O
resulting	599	608	O
in	609	611	O
the	612	615	O
inducement	616	626	O
of	627	629	O
capillary	630	639	B-Tissue
growth	640	646	O
.	646	647	O

In	648	650	O
an	651	653	O
animal	654	660	O
experiment	661	671	O
,	671	672	O
marrow	673	679	B-Cell
cells	680	685	I-Cell
were	686	690	O
infiltrated	691	702	O
into	703	707	O
the	708	711	O
walls	712	717	O
of	718	720	O
long	721	725	O
-	725	726	O
fibril	726	732	O
expanded	733	741	O
polytetrafluoroethylene	742	765	O
(	766	767	O
ePTFE	767	772	O
)	772	773	O
vascular	774	782	O
grafts	783	789	O
.	789	790	O

The	791	794	O
grafts	795	801	O
were	802	806	O
implanted	807	816	O
in	817	819	O
the	820	823	O
abdominal	824	833	B-Multi-tissue_structure
aortic	834	840	I-Multi-tissue_structure
position	841	849	O
of	850	852	O
24	853	855	O
dogs	856	860	B-Organism
autologously	861	873	O
.	873	874	O

Marrow	875	881	B-Cell
cells	882	887	I-Cell
survived	888	896	O
and	897	900	O
continued	901	910	O
exogenous	911	920	O
hemopoiesis	921	932	O
for	933	936	O
up	937	939	O
to	940	942	O
six	943	946	O
months	947	953	O
and	954	957	O
were	958	962	O
immunohistochemically	963	984	O
reactive	985	993	O
to	994	996	O
basic	997	1002	B-Gene_or_gene_product
fibroblast	1003	1013	I-Gene_or_gene_product
growth	1014	1020	I-Gene_or_gene_product
factor	1021	1027	I-Gene_or_gene_product
(	1028	1029	O
bFGF	1029	1033	B-Gene_or_gene_product
)	1033	1034	O
.	1034	1035	O

All	1036	1039	O
the	1040	1043	O
grafts	1044	1050	O
older	1051	1056	O
than	1057	1061	O
three	1062	1067	O
weeks	1068	1073	O
had	1074	1077	O
complete	1078	1086	O
endothelialization	1087	1105	O
and	1106	1109	O
maintained	1110	1120	O
their	1121	1126	O
patency	1127	1134	O
.	1134	1135	O

Twenty	1136	1142	O
grafts	1143	1149	O
without	1150	1157	O
bone	1158	1162	B-Multi-tissue_structure
marrow	1163	1169	I-Multi-tissue_structure
were	1170	1174	O
implanted	1175	1184	O
as	1185	1187	O
controls	1188	1196	O
.	1196	1197	O

Endothelialization	1198	1216	O
was	1217	1220	O
present	1221	1228	O
at	1229	1231	O
anastomotic	1232	1243	O
sites	1244	1249	O
,	1249	1250	O
but	1251	1254	O
other	1255	1260	O
areas	1261	1266	O
were	1267	1271	O
covered	1272	1279	O
with	1280	1284	O
fresh	1285	1290	O
thrombi	1291	1298	O
.	1298	1299	O

Four	1300	1304	O
out	1305	1308	O
of	1309	1311	O
seven	1312	1317	O
control	1318	1325	O
grafts	1326	1332	O
were	1333	1337	O
patent	1338	1344	O
with	1345	1349	O
endothelial	1350	1361	B-Cell
cell	1362	1366	I-Cell
lining	1367	1373	O
at	1374	1376	O
six	1377	1380	O
months	1381	1387	O
,	1387	1388	O
but	1389	1392	O
three	1393	1398	O
were	1399	1403	O
occluded	1404	1412	O
and	1413	1416	O
one	1417	1420	O
of	1421	1423	O
the	1424	1427	O
four	1428	1432	O
grafts	1433	1439	O
was	1440	1443	O
still	1444	1449	O
covered	1450	1457	O
with	1458	1462	O
a	1463	1464	O
thrombus	1465	1473	B-Pathological_formation
layer	1474	1479	O
.	1479	1480	O

Bone	1481	1485	B-Multi-tissue_structure
marrow	1486	1492	I-Multi-tissue_structure
with	1493	1497	O
its	1498	1501	O
unique	1502	1508	O
native	1509	1515	O
properties	1516	1526	O
produced	1527	1535	O
autocrine	1536	1545	O
angiogenicity	1546	1559	O
in	1560	1562	O
the	1563	1566	O
graft	1567	1572	O
.	1572	1573	O

